Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients

被引:81
|
作者
Douiri, Abdel [1 ]
McKevitt, Christopher
Emmett, Eva S.
Rudd, Anthony G.
Wolfe, Charles D. A.
机构
[1] Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England
关键词
drug therapy; mild cognitive impairment; prevention & control; stroke; vascular dementia; HEALTH-CARE PROFESSIONALS; TRANSIENT ISCHEMIC ATTACK; MINI-MENTAL-STATE; GUIDELINES; IMPAIRMENT; DEMENTIA; MANAGEMENT;
D O I
10.1161/CIRCULATIONAHA.113.002236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Limited long-term follow-up data exist on the impact of appropriate secondary prevention therapies on cognitive function in patients after first-ever stroke. The aim of this study is to determine the effect of secondary prevention of vascular events on cognitive function after stroke. Methods and Results Data were collected between 1995 and 2011 (n=4413) from the community-based South London Stroke Register covering an inner-city multiethnic source population of 271 817 inhabitants. Modified Poisson regression models were constructed to adjust for cognitive function status at 3 months, demographic and socioeconomic characteristics, case mix, stroke subtype, vascular risk factors, disability, and stroke recurrence. In patients with ischemic strokes without a history of atrial fibrillation (AF), there was a reduced risk of cognitive impairment associated with the use of different prevention treatments: (1) antihypertensives (relative risk, 0.7 [95% confidence interval, 0.57-0.82] for diuretics; relative risk, 0.8 [95% confidence interval, 0.64-0.98] for angiotensin-converting enzyme inhibitors; and relative risk, 0.7 [95% confidence interval, 0.55-0.81] for their combination), (2) a combination of aspirin and dipyridamole (relative risk, 0.8 [95% confidence interval, 0.68-1.01]), and (3) statin (relative risk, 0.9 [95% confidence interval, 0.76-1.06]) when clinically indicated. Protective effects against cognitive impairment were also observed in patients on the combination of antihypertensives, antithrombotic agents, and lipid-lowering drugs (relative risk, 0.55 [95% confidence interval, 0.40-0.77]). No significant associations were noted between poststroke cognitive impairment and antihypertensives among hemorrhagic stroke patients. Conclusions Appropriate vascular risk management was associated with a long-term reduced risk of cognitive impairment. Focus on optimal preventive drug therapy of vascular risk factors and management should be supported.
引用
收藏
页码:1341 / 1348
页数:8
相关论文
共 50 条
  • [21] Long-term effectiveness of secondary prevention in patients with acute coronary syndrome
    Ryzhikova, I. B.
    Pogosova, N. V.
    Koltunov, I. E.
    Pozdnyakov, Yu. M.
    Vygodin, V. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (07): : 59 - 63
  • [22] Identification of patients at risk of ischemic events for long-term secondary prevention
    Brassard, Andrea
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (12): : 677 - 689
  • [23] Long-term cognitive function in survivors of first-ever ischemic stroke
    Rush, Beth K.
    Brott, Thomas G.
    Brown, Robert D., Jr.
    Silliman, Scott L.
    Gamble, Dale M.
    Luke, Sothear H.
    Richie, Alexa N.
    Albers, Colleen S.
    McNeil, Rebecca B.
    Trejo, Jorge A.
    Meschia, James F.
    STROKE, 2008, 39 (02) : 707 - 707
  • [24] Long-term disability after lacunar stroke Secondary prevention of small subcortical strokes
    Dhamoon, Mandip S.
    McClure, Leslie A.
    White, Carole L.
    Lakshminarayan, Kamakshi
    Benavente, Oscar R.
    Elkind, Mitchell S. V.
    NEUROLOGY, 2015, 84 (10) : 1002 - 1008
  • [25] Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry
    Gutierrez-Zuniga, Raquel
    Rigual, Ricardo
    Torres-Iglesias, Gabriel
    Sanchez-Velasco, Sara
    Alonso de Lecinana, Maria
    Masjuan, Jaime
    Alvarez Velasco, Rodrigo
    Navas, Inmaculada
    Izquierdo-Esteban, Laura
    Fernandez-Ferro, Jose
    Rodriguez-Pardo, Jorge
    Ruiz-Ares, Gerardo
    Zapata-Wainberg, Gustavo
    Fuentes, Blanca
    Diez-Tejedor, Exuperio
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [26] Effects of Age on Long-Term Functional Recovery in Patients with Stroke
    Yoo, Jae Wan
    Hong, Bo Young
    Jo, Leechan
    Kim, Joon-Sung
    Park, Jung Geun
    Shin, Bo Kyung
    Lim, Seong Hoon
    MEDICINA-LITHUANIA, 2020, 56 (09): : 1 - 8
  • [27] Acute and long-term effects of chemotherapy on cognitive function among Indian breast cancer patients
    Singh, Priti
    Leon, Chaithanya
    Kaur, Simran
    Batra, Atul
    Tayade, Prashant
    Prakash, Muthukrishnan Suriya
    Sharma, Ratna
    ECANCERMEDICALSCIENCE, 2025, 19
  • [28] Long-term effects of COVID-19 on cerebrovascular function in patients with mild cognitive impairment
    Owens, Cameron
    Mukli, Peter
    Pinto, Camila Bonin
    Detwiler, Sam
    Tarantini, Stefano
    Hoffmeister, Jordan
    Csiszar, Anna
    Ungvari, Zoltan
    Kirkpatrick, Angelia
    Prodan, Calin
    Yabluchanskiy, Andriy
    PHYSIOLOGY, 2023, 38
  • [29] Exercise Effects On Cognitive Function And Quality Of Life In Alzheimer'S Patients In Long-term Care
    Shaw, Ina
    Cronje, Melany
    Brown, Gregory A.
    Shaw, Brandon S.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2021, 53 (08): : 250 - 250
  • [30] Long-term cognitive effects of oxcarbazepine monotherapy in epilepsy patients
    Park, S
    Lee, H
    Jung, D
    Suh, C
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S138 - S138